HBIO vs ISRG · rev $22.7M vs P/E 80, rev $2.89B
Harvard Bioscience Inc (HBIO) versus Intuitive Surgical Inc (ISRG) — a side-by-side from cached financials, not a winner call.
Harvard Bioscience Inc (HBIO) is a medical instruments & supplies company listed on US.
Intuitive Surgical Inc (ISRG) is a medical instruments & supplies company listed on US.
Latest reported HBIO revenue for 2026-06-30 was $22.7M. Net income was -$2.9M. Revenue was up 9.5% from 2026-03-31 to 2026-06-30. HBIO currently screens at market cap $20.3M.
Latest reported ISRG revenue for 2026-06-30 was $2.89B. Net income was $818.1M. Revenue was up 4.4% from 2026-03-31 to 2026-06-30. ISRG currently screens at market cap $195.15B and trailing P/E 80.0.
HBIO currently screens at market cap $20.3M. ISRG currently screens at market cap $195.15B and trailing P/E 80.0.
Not investment advice. Open the HBIO and ISRG stock pages for the full models.
Not investment advice.